Lucid Diagnostics (LUCD) Net Cash Flow (2020 - 2026)

Lucid Diagnostics' Net Cash Flow history runs 7 years deep, the most recent figure standing at -$6.8 million for Q1 2026.

• Quarterly Net Cash Flow fell 337.12% year-over-year to -$6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (up 462.47% YoY) and the FY2025 annual result came in at $12.3 million, up 256.64% from the prior year.
• Net Cash Flow was -$6.8 million for Q1 2026 at Lucid Diagnostics, up from -$12.6 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $17.0 million in Q1 2023 and bottomed at -$15.2 million in Q2 2022.
• A 5-year average of -$1.5 million and a median of -$5.2 million in 2023 frame the typical range for Net Cash Flow.
• Annual changes were most pronounced in 2022 — Net Cash Flow tumbled 23804.17% — and 2025, when it surged 3797.35%.
• Lucid Diagnostics' Net Cash Flow stood at -$4.5 million in 2022, then fell by 15.56% to -$5.2 million in 2023, then jumped by 252.68% to $7.9 million in 2024, then slumped by 260.55% to -$12.6 million in 2025, then surged by 45.95% to -$6.8 million in 2026.
• Business Quant data shows LUCD's Net Cash Flow at -$6.8 million in Q1 2026, -$12.6 million in Q4 2025, and $16.2 million in Q3 2025.